Matches in SemOpenAlex for { <https://semopenalex.org/work/W2215334832> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2215334832 endingPage "1458" @default.
- W2215334832 startingPage "1457" @default.
- W2215334832 abstract "In Jonathan Rosenberg (New York, NY, USA) and colleagues' phase 2 trial IMvigor 210, 311 assessable adults with locally advanced or metastatic urothelial carcinoma received atezolizumab (1200 mg, intravenously, on the first day of every 21-day cycle) until loss of clinical benefit. Proportion of patients achieving overall response as per RECIST was 15% (95% CI 11–20; p=0·0058), 18% (13–24; p=0·0004) with PD-L1 expression of at least 1% to less than 5%, and 27% (19–37; p<0·0001) with PD-L1 expression of at least 5%. 66% of patients had treatment-related adverse events." @default.
- W2215334832 created "2016-06-24" @default.
- W2215334832 creator A5070862069 @default.
- W2215334832 date "2015-11-01" @default.
- W2215334832 modified "2023-09-27" @default.
- W2215334832 title "2015 European Cancer Congress" @default.
- W2215334832 doi "https://doi.org/10.1016/s1470-2045(15)00378-2" @default.
- W2215334832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30305251" @default.
- W2215334832 hasPublicationYear "2015" @default.
- W2215334832 type Work @default.
- W2215334832 sameAs 2215334832 @default.
- W2215334832 citedByCount "0" @default.
- W2215334832 crossrefType "journal-article" @default.
- W2215334832 hasAuthorship W2215334832A5070862069 @default.
- W2215334832 hasConcept C121608353 @default.
- W2215334832 hasConcept C126322002 @default.
- W2215334832 hasConcept C143998085 @default.
- W2215334832 hasConcept C197934379 @default.
- W2215334832 hasConcept C2775949291 @default.
- W2215334832 hasConcept C2777701055 @default.
- W2215334832 hasConcept C2780057760 @default.
- W2215334832 hasConcept C2780352672 @default.
- W2215334832 hasConcept C2911057145 @default.
- W2215334832 hasConcept C3019882237 @default.
- W2215334832 hasConcept C3020745361 @default.
- W2215334832 hasConcept C535046627 @default.
- W2215334832 hasConcept C71924100 @default.
- W2215334832 hasConceptScore W2215334832C121608353 @default.
- W2215334832 hasConceptScore W2215334832C126322002 @default.
- W2215334832 hasConceptScore W2215334832C143998085 @default.
- W2215334832 hasConceptScore W2215334832C197934379 @default.
- W2215334832 hasConceptScore W2215334832C2775949291 @default.
- W2215334832 hasConceptScore W2215334832C2777701055 @default.
- W2215334832 hasConceptScore W2215334832C2780057760 @default.
- W2215334832 hasConceptScore W2215334832C2780352672 @default.
- W2215334832 hasConceptScore W2215334832C2911057145 @default.
- W2215334832 hasConceptScore W2215334832C3019882237 @default.
- W2215334832 hasConceptScore W2215334832C3020745361 @default.
- W2215334832 hasConceptScore W2215334832C535046627 @default.
- W2215334832 hasConceptScore W2215334832C71924100 @default.
- W2215334832 hasIssue "15" @default.
- W2215334832 hasLocation W22153348321 @default.
- W2215334832 hasLocation W22153348322 @default.
- W2215334832 hasOpenAccess W2215334832 @default.
- W2215334832 hasPrimaryLocation W22153348321 @default.
- W2215334832 hasRelatedWork W2565577774 @default.
- W2215334832 hasRelatedWork W2889691772 @default.
- W2215334832 hasRelatedWork W2904110710 @default.
- W2215334832 hasRelatedWork W2947269397 @default.
- W2215334832 hasRelatedWork W2961042511 @default.
- W2215334832 hasRelatedWork W3012957547 @default.
- W2215334832 hasRelatedWork W3028814175 @default.
- W2215334832 hasRelatedWork W3090399456 @default.
- W2215334832 hasRelatedWork W3202746846 @default.
- W2215334832 hasRelatedWork W4319955432 @default.
- W2215334832 hasVolume "16" @default.
- W2215334832 isParatext "false" @default.
- W2215334832 isRetracted "false" @default.
- W2215334832 magId "2215334832" @default.
- W2215334832 workType "article" @default.